創薬の世界市場レポート 2025

創薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR15.3％で2,217億1,000万米ドルに成長します。予測期間の成長は、精密医療の採用、希少疾患への注力、個別化治療の拡大に起因すると考えられます。予測期間における主な動向には、共同研究創薬モデル、希少疾患と希少疾病治療薬への注目、マルチオミクスデータの統合、オルガノイドと3D細胞培養モデルの急速な採用、バーチャルスクリーニングの進歩などが含まれます。

ヘルスケア支出の増加は、今後数年間で創薬市場を押し上げると予想されます。世界各国はGDPのかなりの部分を医療費に充てており、その中には病院医療、医師および臨床サービス、各種専門サービス、歯科サービス、その他の医療サービス、住宅およびパーソナルケア、在宅医療、介護施設、継続ケア退職者コミュニティ、処方薬などが含まれます。創薬は、疾病の治療と寿命の延長に不可欠であるため、保健支出の極めて重要な要素です。新たな疾病に対処するための新薬の需要は高まっています。例えば、2024年10月、米国の連邦政府機関であるメディケア・メディケイド・サービスセンターは、2022年の国民医療費が4.1％増の4兆5,000億米ドル、1人当たり1万3,493米ドルになったと報告しました。2023年から2032年にかけて、国民医療費の平均成長率（5.6％）はGDPの平均成長率（4.3％）を上回ると予測されており、その結果、GDPに占める医療費の割合は2022年の17.3％から2032年には19.7％に増加します。このように、ヘルスケア支出の増加が創薬市場の成長を牽引しています。

創薬市場は、製薬・バイオテクノロジー分野での研究開発（R&D）支出の増加によって成長する態勢が整っています。製薬・バイオテクノロジー分野の研究開発費には、新製品や新技術の発見・開発に重点を置いた研究開発活動のための資金配分が含まれます。このような研究開発活動への資金投入は、疾病メカニズムの理解を進め、前臨床試験を実施し、臨床試験を経て、最終的に新薬や治療法の開発に貢献するために不可欠です。その一例として、英国政府は2022年、研究開発への支出を大幅に増やし、2024/25年までに年間200億ポンド（254億3,000万円）に達するよう、53億6,000万ポンド（6,600億円）を追加すると発表しました。この資金投入は、2027年までに全分野を含む研究開発支出総額をGDPの2.4%にするという目標を達成するための政府戦略の一環です。製薬・バイオテクノロジー分野における研究開発費の大幅な伸びは、創薬の進歩に対する業界のコミットメントを強調するものであり、創薬市場全体の成長を促進するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界創薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の創薬市場：成長率分析
• 世界の創薬市場の実績：規模と成長, 2019-2024
• 世界の創薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界創薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の創薬市場薬剤の種類別：、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小分子
• 巨大分子
• 世界の創薬市場：プロセス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ターゲットの選択
• ターゲット検証
• ヒットからリードまでの識別
• リード最適化
• 候補者の検証
• 世界の創薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイスループットスクリーニング
• 分光法
• コンビナトリアルケミストリー
• バイオチップ
• 薬理ゲノム学と薬理遺伝学
• バイオインフォマティクス
• メタボロミクス
• ナノテクノロジー
• その他のテクノロジー
• 世界の創薬市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経学
• 感染症および免疫系疾患
• 消化器疾患
• 心血管疾患
• 糖尿病
• 呼吸器疾患
• その他の治療領域
• 世界の創薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• CRO
• その他のエンドユーザー
• 世界の創薬市場、小分子のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成小分子
• 天然小分子
• 標的小分子薬
• 世界の創薬市場、巨大分子のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• タンパク質とペプチド
• 核酸ベースの治療法

第7章 地域別・国別分析

• 世界の創薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の創薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創薬市場：競合情勢
• 創薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • WuXi AppTec Group Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Eli Lilly and Company
• Laboratory Corporation of America Holdings
• Evotec SE
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Sanofi S.A.
• Charles River Laboratories International Inc.
• Pharmaron Ltd.
• Viva Biotech Ltd.
• Albany Molecular Research Inc.
• Schrodinger Inc.
• BioDuro Ltd.
• Aptuit LLC
• Selvita S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 創薬市場2029：新たな機会を提供する国
• 創薬市場2029：新たな機会を提供するセグメント
• 創薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug discovery is the systematic process of identifying biologically active compounds with therapeutic potential. The journey from ideation to development and approval aims to discover new clinical drugs for treating various diseases, whether they are new, existing, or previously incurable.

The drug discovery market involves two main types of drugs include small molecule and large molecule. Small molecules are utilized to identify compounds with suitable properties for development, referring to low molecular weight drugs that can efficiently penetrate cells. The drug discovery process includes target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Various technologies contribute to drug discovery, such as high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics, pharmacogenetics, bioinformatics, metabolomics, nanotechnology, and others. Drug discovery finds applications in therapeutic areas such as oncology, neurology, infectious and immune system diseases, digestive system diseases, cardiovascular diseases, diabetes, respiratory diseases, and more. Pharmaceutical companies, Contract Research Organizations (CROs), and other end-users engage in drug discovery.

The drug discovery market research report is one of a series of new reports from The Business Research Company that provides drug discovery market statistics, including drug discovery industry global market size, regional shares, competitors with a drug discovery market share, detailed drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery industry. This drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery market size has grown rapidly in recent years. It will grow from $110.26 billion in 2024 to $125.23 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to advancements in genomics and proteomics, expanding prevalence of chronic diseases, emergence of biopharmaceuticals.

The drug discovery market size is expected to see rapid growth in the next few years. It will grow to $221.71 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to precision medicine adoption, focus on rare diseases, expansion of personalized therapies. Major trends in the forecast period include collaborative drug discovery models, focus on rare diseases and orphan drugs, integration of multi-omics data, rapid adoption of organoids and 3D cell culture models, advancements in virtual screening.

The increase in healthcare spending is expected to boost the drug discovery market in the coming years. Countries worldwide are allocating a significant portion of their GDP to healthcare expenses, which encompass hospital care, physician and clinical services, various professional services, dental services, other health services, residential and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription drugs, and more. Drug discovery is a crucial component of health expenditures, as it is essential for treating diseases and extending life. The demand for new medications to address emerging diseases is growing. For example, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure increased by 4.1% to $4.5 trillion in 2022, or $13,493 per person. From 2023 to 2032, the average growth rate of national health expenditure (5.6%) is projected to exceed that of average GDP growth (4.3%), resulting in an increase in the health spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rise in healthcare spending is driving the growth of the drug discovery market.

The drug discovery market is poised for growth, driven by the increasing research and development (R&D) expenditure in the pharma-biotech sector. R&D expenditure in the pharma-biotech sector involves allocating funds for research and development activities, focusing on the discovery and development of new pharmaceutical products and technologies. This financial commitment to R&D activities is essential for advancing the understanding of disease mechanisms, conducting pre-clinical testing, and progressing through clinical trials, ultimately contributing to the development of new medicines and treatments. As an illustration, in 2022, the UK government announced a significant increase in spending on R&D, allocating an additional £5 (6.36) billion to reach £20 (25.43) billion per year by 2024/25. This funding injection is part of the government's strategy to achieve a target of total R&D spending, encompassing all sectors, reaching 2.4% of GDP by 2027. The substantial growth in R&D expenditure in the pharma-biotech sector underscores the industry's commitment to advancing drug discovery, thus propelling the overall growth of the drug discovery market.

Technological advancements play a crucial role in shaping the landscape of the drug discovery market. Companies within this domain are actively incorporating various cutting-edge technologies, including Artificial Intelligence (AI), imaging technology, and others, to streamline and expedite the drug discovery process. This proactive integration of technology aims to reduce the time required for drug discovery, fostering innovation and efficiency in the industry. Imaging technology is a notable aspect of these advancements, enabling the visualization, characterization, and quantification of non-invasive biological activities occurring within organisms in response to medications. These methods, utilizing either probes or the tissue itself, are instrumental in comprehending diseases and identifying novel treatments. As an illustrative example, in May 2023, Google Cloud introduced two AI-powered tools in the drug discovery realm: the Target and Lead Identification Suite and the Multiomics Suite. These tools are designed to empower biotech and pharmaceutical companies by expediting drug discovery and precision medicine efforts. The Target and Lead Identification Suite aids in deciphering the function of amino acids and proteins, while the Multiomics Suite accelerates the discovery and interpretation of genomic data, facilitating the design of precision treatments. This commitment to leveraging advanced technologies exemplifies the industry's dedication to enhancing the drug discovery process through innovative tools and approaches.

Major players in the drug discovery market are actively engaged in creating innovative solutions, such as drug discovery accelerators, to advance the development of sophisticated drug models. Drug discovery accelerators represent various entities, initiatives, or programs meticulously crafted to expedite the intricate process of discovering and developing novel pharmaceutical compounds. An exemplary instance of this commitment to innovation is evident in the collaboration between Novo Nordisk and Evotec. In September 2023, they jointly introduced LAB eN2, a translational drug discovery accelerator. LAB eN2 is specifically crafted to support preclinical research originating from academic institutions, with the ultimate goal of propelling the development of groundbreaking therapeutics. The collaboration's primary focus is to hasten the translation of academic concepts into tangible therapeutic product candidates, particularly within the realms of cardiometabolic disorders, rare blood disorders, and endocrine disorders.

In July 2024, Iktos, a pharmaceutical and biotech company based in France, acquired Synsight for an undisclosed amount. This acquisition seeks to improve Iktos's current platform by incorporating Synsight's advanced technologies, especially its MT Bench system for high-performance screening of biological interactions. Synsight is also a biotechnology company located in France.

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrodinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery market includes revenues earned by entities by high throughput screening, spectroscopy, combinatorial chemistry, biochips, pharmacogenomics and pharmacogenetics, bioinformatics, metabolomics, and nanotechnology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Small Molecule; Large Molecule
• 2) By Process: Target Selection; Target Validation; Hit-To-Lead Identification; Lead Optimization; Candidate Validation
• 3) By Technology: High Throughput Screening; Spectroscopy; Combinatorial Chemistry; Biochips; Pharmacogenomics And Pharmacogenetics; Bioinformatics; Metabolomics; Nanotechnology; Other Technologies
• 4) By Therapeutic Area: Oncology; Neurology; Infectious And Immune System Diseases; Digestive System Diseases; Cardiovascular Diseases; Diabetes; Respiratory Disease; Other Therapeutic Areas
• 5) By End User: Pharmaceutical Companies; CROs; Other End-Users
• Subsegments:
• 1) By Small Molecule: Synthetic Small Molecules; Natural Small Molecules; Targeted Small Molecule Drugs
• 2) By Large Molecule: Monoclonal Antibodies; Proteins And Peptides; Nucleic Acid-Based Therapies
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Novartis International AG; Thermo Fisher Scientific Inc.; WuXi AppTec Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Discovery Market Characteristics

3. Drug Discovery Market Trends And Strategies

4. Drug Discovery Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Discovery Market Growth Rate Analysis
• 5.4. Global Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Discovery Total Addressable Market (TAM)

6. Drug Discovery Market Segmentation

• 6.1. Global Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.2. Global Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation
• 6.3. Global Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Throughput Screening
• Spectroscopy
• Combinatorial Chemistry
• Biochips
• Pharmacogenomics And Pharmacogenetics
• Bioinformatics
• Metabolomics
• Nanotechnology
• Other Technologies
• 6.4. Global Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Infectious And Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Other Therapeutic Areas
• 6.5. Global Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• CROs
• Other End-Users
• 6.6. Global Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Small Molecules
• Natural Small Molecules
• Targeted Small Molecule Drugs
• 6.7. Global Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Proteins And Peptides
• Nucleic Acid-Based Therapies

7. Drug Discovery Market Regional And Country Analysis

• 7.1. Global Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Discovery Market

• 8.1. Asia-Pacific Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Discovery Market

• 9.1. China Drug Discovery Market Overview
• 9.2. China Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Discovery Market

• 10.1. India Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Discovery Market

• 11.1. Japan Drug Discovery Market Overview
• 11.2. Japan Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Discovery Market

• 12.1. Australia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Discovery Market

• 13.1. Indonesia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Discovery Market

• 14.1. South Korea Drug Discovery Market Overview
• 14.2. South Korea Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Discovery Market

• 15.1. Western Europe Drug Discovery Market Overview
• 15.2. Western Europe Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Discovery Market

• 16.1. UK Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Discovery Market

• 17.1. Germany Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Discovery Market

• 18.1. France Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Discovery Market

• 19.1. Italy Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Discovery Market

• 20.1. Spain Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Discovery Market

• 21.1. Eastern Europe Drug Discovery Market Overview
• 21.2. Eastern Europe Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Discovery Market

• 22.1. Russia Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Discovery Market

• 23.1. North America Drug Discovery Market Overview
• 23.2. North America Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Discovery Market

• 24.1. USA Drug Discovery Market Overview
• 24.2. USA Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Discovery Market

• 25.1. Canada Drug Discovery Market Overview
• 25.2. Canada Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Discovery Market

• 26.1. South America Drug Discovery Market Overview
• 26.2. South America Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Discovery Market

• 27.1. Brazil Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Discovery Market

• 28.1. Middle East Drug Discovery Market Overview
• 28.2. Middle East Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Discovery Market

• 29.1. Africa Drug Discovery Market Overview
• 29.2. Africa Drug Discovery Market, Segmentation By Drug Type:, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Discovery Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Discovery Market Competitive Landscape And Company Profiles

• 30.1. Drug Discovery Market Competitive Landscape
• 30.2. Drug Discovery Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. WuXi AppTec Group Overview, Products and Services, Strategy and Financial Analysis

31. Drug Discovery Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Eli Lilly and Company
• 31.3. Laboratory Corporation of America Holdings
• 31.4. Evotec SE
• 31.5. Eurofins Scientific SE
• 31.6. Agilent Technologies Inc.
• 31.7. Sanofi S.A.
• 31.8. Charles River Laboratories International Inc.
• 31.9. Pharmaron Ltd.
• 31.10. Viva Biotech Ltd.
• 31.11. Albany Molecular Research Inc.
• 31.12. Schrodinger Inc.
• 31.13. BioDuro Ltd.
• 31.14. Aptuit LLC
• 31.15. Selvita S.A.

32. Global Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Market

34. Recent Developments In The Drug Discovery Market

35. Drug Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer